FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years

The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc. PFE, +0.42% and German partner BioNTech SE BNTX, -4.17% as well as the one developed by Moderna Inc. MRNA, -6.79% in children aged 6 months to four years old.